The market for structural heart devices is expected to grow at a CAGR of around 10.2% from 2020 to 2027 and expected to reach the market value of around US$19.4 Bn by 2027.
Structural Heart Devices consist of various therapeutic interventional devices that are used to efficiently and economically close an abnormal communication between the heart chambers as well as used to reconstruct or replace a diseased or degenerated heart valve through the adoption of a multidisciplinary remedial approach. These are used in structural heart diseases which are also termed as a non-coronary anomaly of the heart. Structural heart diseases refer to cardiac defects which are inherited by birth and can be developed later in life.
Market Dynamics
The rising prevalence of structural heart diseases and regulatory approvals of new and advanced structural heart devices are supporting market growth. The favorable reimbursement scenario and rising awareness of structural heart diseases are supporting market growth. The product approvals for Medtronic, Edwards Life sciences Corporation, Abbott laboratories, Livanova, and micro interventional devices are further bolstering the market value. Furthermore, percutaneous interventions, approval of TAVR for extended indications, the emergence of tissue-engineered heart valves in emerging countries is projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other hand, low affordability and inaccessibility of cardiac surgeries in developing countries are anticipated to hinder the growth to an extent over the forecast period from 2020 to 2027.
Segment Instance
North America accounted for the maximum revenue share in the global market
In 2019, North America is leading the structural heart devices market with maximum revenue share, and the region is also projected to maintain its dominance throughout the forecast timeframe from 2020 to 2027. The presence of skilled professionals and well-established healthcare infrastructure is supporting regional market growth. The increasing number of people with chronic heart diseases is a major region including the US and Canada is supporting the regional market value. The presence of major players in the region is further bolstering the regional market value. The major players are involved in research and development activities in order to provide more advanced solutions in the healthcare sector for effective patient treatment.
Asia Pacific is projected to experience fastest growth in near future
Asia Pacific is anticipated to experience the fastest growth throughout the forecast timeframe from 2020 to 2027. The developing economies including China and India are supporting the regional market growth. The increasing number of patients with structural heart diseases along with the escalating geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes is further bolstering the regional market value.
Key Market Players
The players profiled in the report include Abbott (US), Boston Scientific Corporation (US), Braile Biomédica (Brazil), CryoLife, Inc. (US), Edwards Lifesciences Corporation (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), LivaNova PLC (UK), Medtronic plc (Ireland), Micro Interventional Devices, Inc. (US), TTK Healthcare Limited (India), and others. The major market players were involved in mergers and acquisitions, partnerships & collaborations, and new source development for the expansion of market share.
Target Market Audience:
Hospitals
Healthcare Corporations
Cardiac Surgery Centers
Structural Heart Device Distributors
Medical Service Providers
Structural Heart Devices Manufacturers
Structural Heart Surgeons
Market Segmentation
Market By Product
Heart Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Other Devices
Accessories
Market By Procedure
Replacement Procedures
- TAVR Procedures
- SAVR Procedures
Repair Procedures
- Closure Procedures
- Annuloplasty
- Valvuloplasty
- TMVR Procedures
Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Structural Heart Devices
1.1. Definition and Scope
1.1.1. Definition of Structural Heart Devices
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Structural Heart Devices Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Structural Heart Devices Market By Product
1.2.3. Structural Heart Devices Market By Procedure
1.2.4. Structural Heart Devices Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Structural Heart Devices Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Structural Heart Devices Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Structural Heart Devices Major Manufacturers in 2019
CHAPTER 5. Structural Heart Devices Market By Product
5.1. Introduction
5.2. Structural Heart Devices Revenue By Product
5.2.1. Structural Heart Devices Revenue (US$ Mn) and Forecast, By Product, 2016-2027
5.2.2. Herat Valve Devices
5.2.2.1. Herat Valve Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Surgical Heart Valves
5.2.3.1. Surgical Heart Valves Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Transcatheter Heart Valves
5.2.4.1. Transcatheter Heart Valves Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Occluders and Delivery Systems
5.2.5.1. Occluders and Delivery Systems Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Annuloplasty Rings
5.2.6.1. Annuloplasty Rings Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Accessories
5.2.7.1. Accessories Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Other Devices
5.2.8.1. Other Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Structural Heart Devices Market Revenue By Procedure
6.1. Introduction
6.2. Structural Heart Devices Revenue (US$ Mn) By Procedure
6.2.1. Structural Heart Devices Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
6.2.2. Replacement Procedures
6.2.2.1. Replacement Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. TAVR Procedures
6.2.3.1. TAVR Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. SAVR Procedures
6.2.4.1. SAVR Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Repair Procedures
6.2.5.1. Repair Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Closure Procedures
6.2.6.1. Closure Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Annuloplasty
6.2.7.1. Annuloplasty Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.8. Valvuloplasty
6.2.8.1. Valvuloplasty Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.9. TMVR Procedures
6.2.9.1. TMVR Procedures Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Structural Heart Devices Market By Country
7.1. North America Structural Heart Devices Overview
7.2. U.S.
7.2.1. U.S. Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
7.3. Canada
7.3.1. Canada Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Structural Heart Devices Market By Country
8.1. Europe Bioanlytical Testing Services Market Overview
8.2. U.K.
8.2.1. U.K. Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
8.3. Germany
8.3.1. Germany Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
8.4. France
8.4.1. France Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
8.5. Spain
8.5.1. Spain Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Structural Heart Devices Market By Country
9.1. Asia Pacific Structural Heart Devices Market Overview
9.2. China
9.2.1. China Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.3. Japan
9.3.1. Japan Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.4. India
9.4.1. India Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.5. Australia
9.5.1. Australia Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Structural Heart Devices Market By Country
10.1. Latin America Structural Heart Devices Market Overview
10.2. Brazil
10.2.1. Brazil Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
CHAPTER 11. Middle East & Africa Structural Heart Devices Market By Country
11.1. Middle East & Africa Structural Heart Devices Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
11.3. UAE
11.3.1. UAE Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Structural Heart Devices Market Revenue (US$ Mn) and Forecast By Procedure, 2016 - 2027
CHAPTER 12. Player Analysis Of Structural Heart Devices
12.1. Structural Heart Devices Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Structural Heart Devices Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Abbott (US)
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Abbott (US) 2019 Structural Heart Devices Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Boston Scientific Corporation (US)
13.3. Braile Biomédica (Brazil)
13.4. CryoLife, Inc. (US)
13.5. Edwards Lifesciences Corporation (US)
13.6. Lepu Medical Technology (Beijing)Co., Ltd. (China)
13.7. LivaNova PLC (UK)
13.8. Medtronic plc (Ireland)
13.9. Micro Interventional Devices, Inc. (US)
13.10. TTK Healthcare Limited (India)
13.11. Others
![Structural Heart Devices Market (By Product: Herat Valve Devices [Surgical Heart Valves, Transcatheter Heart Valves], Occluders and Delivery Systems, Annuloplasty Rings, Other Devices, Accessories; By Procedure: Replacement Procedures [TAVR Procedures, SAVR Procedures], Repair Procedures [Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures]) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027](assets/images/format-png.png "Structural Heart Devices Market (By Product: Herat Valve Devices [Surgical Heart Valves, Transcatheter Heart Valves], Occluders and Delivery Systems, Annuloplasty Rings, Other Devices, Accessories; By Procedure: Replacement Procedures [TAVR Procedures, SAVR Procedures], Repair Procedures [Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures]) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027")
